31 min listen
? Maneesh Jain - Mirvie - Part 1 | Fundamental Curiosity & The Value of Perseverance | Entrepreneurship for Societal Impact | “Magic Decades” & Findin…
? Maneesh Jain - Mirvie - Part 1 | Fundamental Curiosity & The Value of Perseverance | Entrepreneurship for Societal Impact | “Magic Decades” & Findin…
ratings:
Length:
31 minutes
Released:
Oct 4, 2023
Format:
Podcast episode
Description
Part 1 of 3.
My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. Before Mirvie, Maneesh was a founder, CEO, or executive of five successful start-ups, which include Parallele Bioscience, Auriphex Bioscience, Ion Torrent, Butterfly Network, and Cirina.
My guest for this week’s episode is Maneesh Jain, CEO and Co-Founder of Mirvie, a life science company that predicts pregnancy complications before they happen by revealing the underlying biology of pregnancy health. Mirvie is dedicated to shaping the future of pregnancy health through simple, personalized blood tests. Before Mirvie, Maneesh was a founder, CEO, or executive of five successful start-ups, which include Parallele Bioscience, Auriphex Bioscience, Ion Torrent, Butterfly Network, and Cirina.
Released:
Oct 4, 2023
Format:
Podcast episode
Titles in the series (44)
Jacob Glanville - Centivax - Part 2 | Creating Bioinformatic Tools | Innovation vs. Organization in Biotech Companies | Finding Excitement in Your Work | Tech Transfer & “Separation of Church and State”: In part 2 of the Biotech Startups Podcast episode, host Jon Chee dives deeper into his conversation with Jacob Glanville, Founder, CEO, & President of Centivax. Jake sheds light on his past experiences at Rinat Labs, a Pfizer company, and how he found a way to leverage his skills and experience to create new bioinformatic processes. Learn more about his initial idea for a universal vaccine and why he chose to pursue a PhD at Stanford. by The Biotech Startups Podcast